Titan Pharmaceuticals Inc (TTNP)
7.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
Titan Pharmaceuticals Free Cash Flow: -7.092M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.092M |
| September 30, 2023 | -6.425M |
| June 30, 2023 | -6.463M |
| March 31, 2023 | -7.118M |
| December 31, 2022 | -8.183M |
| September 30, 2022 | -7.685M |
| June 30, 2022 | -8.074M |
| March 31, 2022 | -8.238M |
| December 31, 2021 | -7.922M |
| September 30, 2021 | -11.41M |
| June 30, 2021 | -13.04M |
| March 31, 2021 | -15.13M |
| December 31, 2020 | -17.74M |
| September 30, 2020 | -16.95M |
| June 30, 2020 | -16.44M |
| March 31, 2020 | -16.59M |
| December 31, 2019 | -15.70M |
| September 30, 2019 | -15.58M |
| June 30, 2019 | -14.48M |
| March 31, 2019 | -12.14M |
| December 31, 2018 | -8.847M |
| September 30, 2018 | -8.716M |
| June 30, 2018 | -10.10M |
| March 31, 2018 | -10.77M |
| December 31, 2017 | -12.85M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.81M |
| June 30, 2017 | -10.96M |
| March 31, 2017 | 5.081M |
| December 31, 2016 | 6.122M |
| September 30, 2016 | 6.772M |
| June 30, 2016 | 7.779M |
| March 31, 2016 | -7.661M |
| December 31, 2015 | -7.599M |
| September 30, 2015 | -7.338M |
| June 30, 2015 | -6.932M |
| March 31, 2015 | -6.357M |
| December 31, 2014 | -5.883M |
| September 30, 2014 | -6.436M |
| June 30, 2014 | -7.211M |
| March 31, 2014 | -9.792M |
| December 31, 2013 | -10.12M |
| September 30, 2013 | 1.372M |
| June 30, 2013 | 1.04M |
| March 31, 2013 | 1.846M |
| December 31, 2012 | 0.676M |
| September 30, 2012 | -11.05M |
| June 30, 2012 | -11.86M |
| March 31, 2012 | -15.66M |
| December 31, 2011 | -14.71M |
| September 30, 2011 | -15.30M |
Free Cash Flow Range, Past 5 Years
-17.74M
Minimum
Dec 2020
-6.425M
Maximum
Sep 2023
-11.59M
Average
-11.41M
Median
Sep 2021
Free Cash Flow Benchmarks
| Outset Medical Inc | -134.81M |
| Allurion Technologies Inc | -65.59M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.246M |
| Cash from Investing (Quarterly) | 0.504M |
| Cash from Financing (Quarterly) | 0.406M |
| Free Cash Flow Per Share (Quarterly) | -2.972 |
| Free Cash Flow Yield | -132.8% |